FDA Updates

FDA approved Sandoz’s generic version of Copaxone (glatiramer acetate injection) known as Glatopa, making it the first generic version of the drug available for patients with relapsing forms of multiple sclerosis.

FDA approved tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim Pharmaceuticals) inhalation spray for the long-term, once-daily maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD) and to reduce exacerbations in patients with COPD.

It's back-to-school season. Mom and Dad can be losing their hair for a few reasons - finding something crawling on the kids' heads is just the beginning. Here's a host of solutions for parents and their young.

FDA has approved pembrolizumab (Keytruda, Merck) for treatment of patients with advanced or unresectable melanoma who are no longer responding to other drugs. Pembrolizumab, which received breakthrough therapy designation for advanced melanoma, is the sixth new melanoma treatment approved since 2011.

A University of Kentucky pharmacy professor has developed a quicker, easier way to deliver naloxone via a nasal spray, and his invention is being fast-tracked by the Food and Drug Administration, according to a report in the Lexington Herald-Leader.